AIDTriage LLC is developing a breakthrough handheld diagnostic platform designed to rapidly detect infectious agents at the point of care. By combining microfluidic small-volume testing, DNA/RNA fluorescence chemistry, smartphone-based imaging, and AI-assisted analysis, AIDTriage delivers actionable diagnostic insights within minutes, long before traditional laboratory testing is available.
Our platform is engineered for clinics, urgent care centers, field hospitals, and low-resource environments where rapid triage can dramatically improve patient outcomes. Whether during routine care or emerging outbreaks, AIDTriage empowers clinicians with fast, reliable infection-type differentiation.
Make early infection detection fast, affordable, and universally accessible.
See how it works
Leads AIDTriage’s strategic direction, R&D operations, and AI-driven diagnostic innovation. She serves as Chief Executive Officer (2026–present) and Chief Intelligence Officer (2025–present), guiding the development of microfluidic testing, fluorescence-based detection, and machine-learning analysis across the platform. She has been engaged with AIDTriage’s scientific and technical development since its inception.
Emeritus Professor and member of the Emeritus College, recognized for decades of scientific leadership and continued contributions to research, innovation, and mentoring. She is an ASU Professor of Physics Emeritus and an inducted member of the National Academy of Inventors (2018).
Dr. Herbots provides scientific leadership and direct guidance to the entire AIDTriage team. She oversees R&D operations, ensuring that all engineering, laboratory, and diagnostic-development efforts operate under her expertise. Her direction guarantees that the platform’s chemistry, microscale detection methods, and fluorescence-analysis models are grounded in rigorous scientific principles and validated laboratory workflows.
Oversees device engineering, system integration, and market strategy. Her engineering team works under Dr. Herbots’ scientific direction to ensure that hardware design, optical modules, and microfluidic systems meet laboratory-validated performance standards.
Leads clinical validation, medical workflow design, and laboratory operations. Her team collaborates closely with Dr. Herbots to align fluorescence-signature interpretation, microbial-load calibration, and diagnostic accuracy with real-world clinical needs.
Leads scientific strategy, research direction, and innovation across all diagnostic-development programs. He oversees cross-disciplinary scientific initiatives supporting fluorescence-based detection, microfluidic optimization, and sensor-level performance improvements.
Responsible for technical architecture, device engineering, system integration, and hardware-software alignment. She directs the development of the smartphone-based imaging module, optical systems, and prototype engineering workflows.
Oversees scientific communication, stakeholder engagement, outreach strategy, and public-facing content. She ensures that AIDTriage’s mission, technology, and research achievements are communicated clearly to clinicians, partners, and investors.
Contributes to AIDTriage’s laboratory research and data-analysis pipeline, including microbial culturing, fluorescence-signature characterization, agar-plate calibration studies, and AI dataset preparation. He supports both microbiology workflows and machine-learning model development.
To provide healthcare providers with rapid, reliable infection-triage tools that improve decision-making and strengthen global preparedness for infectious-disease threats.
Faster identification of infection type enables earlier, more effective treatment.
Differentiating viral from bacterial infections reduces unnecessary antibiotic use.
Our platform detects infection signatures even before pathogen-specific tests exist.
Designed for point-of-care use in both advanced and resource-limited settings.
We aim to democratize diagnostic capability by delivering laboratory-grade insights through a portable, low-cost device.
AIDTriage’s diagnostic platform is built on four core pillars, from sample to result.
Our microfluidic chamber processes microliter-scale samples such as saliva, nasal swabs, or wound fluid.
Disposable cartridges ensure sterility and low-cost scalability.
Our detection chemistry binds to nucleic acid structures associated with viral, bacterial, and fungal pathogens. When activated by 470 nm blue-light irradiation, these markers emit fluorescence signatures that vary based on pathogen type, nucleic acid density, microbial load, and structural integrity.
These fluorescence patterns form the foundation of our diagnostic signal.
AIDTriage leverages the high-resolution cameras already present in modern smartphones. This dramatically reduces device cost while maintaining high diagnostic accuracy.
Our optical module standardizes:
Captured fluorescence images are processed through machine-learning models trained on thousands of laboratory samples.
Results are delivered in minutes through a clinician-friendly interface.
Our R&D pipeline includes rigorous laboratory workflows that support model training and calibration.
We culture bacterial and viral samples on agar plates to:
LabVida fluorescence slides provide high-resolution fluorescence capture, consistent substrate conditions, and reliable RGB data.
These slides form benchmark datasets for device validation.
Our excitation module uses 470 nm LEDs chosen for:
Microscopic imaging of T4 bacteriophage infections helps us understand:
This data is essential for early viral detection.
Our handheld prototype integrates all core technologies into a compact, portable device.
The prototype is currently undergoing laboratory validation and early-stage field testing.
Interested in partnering, investing, piloting AIDTriage or joining our research? We’d love to hear from you. Send us an email and our team will get back to you.